药物对比
Linagliptin vs Rosiglitazone
比较 Linagliptin（Tradjenta）与 Rosiglitazone：DPP-4抑制剂与TZD治疗2型糖尿病。回顾疗效、副作用、心血管风险和患者因素。
此页面暂无可用的对比维度。
临床背景
This comparison occurs when choosing between DPP-4 inhibitors and thiazolidinediones as oral options for type 2 diabetes management.
结论
The preferred agent depends on patient comorbidities, hypoglycemia risk, and cardiovascular profile rather than one being superior.
全部药物对比